Log In
Print
BCIQ
Print
Print this Print this
 

RGN-137

  Manage Alerts
Collapse Summary General Information
Company RegeneRx Biopharmaceuticals Inc.
DescriptionTopical formulation of synthetic thymosin beta 4 (TB4), a naturally occurring 43-amino acid peptide
Molecular Target Thymosin beta 4 (TB4)
Mechanism of ActionNA
Therapeutic ModalityPeptide

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$14.4M

$0.6M

$10.6M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today